| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Calluna Pharma Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source. Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases. Type: | 0 | 0 | 0 | 15 |
 | Carcinotech Ltd Enabling Cancer Treatment Breakthroughs Carcinotech provides comprehensive solid tumour research services to therapeutic developers and healthcare professionals. At the heart of its offerings is the proprietary Carcino3DTM bioprinting platform, which creates assay-ready, 3D tumours from patient biopsies. Unlike conventional cancer models, Carcinotech’s bioprinted constructs incorporate multiple cell types—including immune cell populations—within a robust tissue matrix, offering a more biologically relevant and controlled model for early drug discovery, preclinical and co-clinical studies, and personalised treatment testing. Cancer research, 3D bioprinting , Drug discovery , Cancer microenvironment, Personalised medicine testing, drug testing, oncology, assay services, oncology pre-clinical services, solid tumours, solid tumors, … Type: | 2 | 0 | 1 | 20 |
 |  IMU Biosciences Mapping the immune system across health and disease to power precision medicine Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics. digital health, immunology, immune medicine, precision medicine, and AI/ML Type: | 4 | 0 | 4 | 44 |
 | Scailyte True precision medicine through single-cell science. True precision medicine through single-cell science. Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles. The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality. If you want to partner with, reach out … Type: | 3 | 0 | 3 | 22 |
 | Libre Foods We work with the brilliance of fungi to reinvent food as you know it. We are an R&D-driven biotech startup making groundbreaking advancements in fungi-based proteins 🍄 We are commercializing a platform of high-quality fungi-based products starting with our fungi-based Libre Bacon and following with our newest innovation: mycelium-based Libre Chicken. Our mission is to reinvent meat with the power of fungi to empower consumers to make conscious choices for a healthier future. Startup , Scaleup, Fungi-based, Mycelium, Mushroom, Foodtech, Plant-based, Impact, Environment, Food technology, Sustainability, Biotech, Climate-tech, Whole cut meat, Food system, Meat alternatives, Animal welfare, Europe, Barcelona, Diversity, … Type: | 3 | 1 | 3 | 30 |
 | EsoBiotec We Empower Cells In Vivo to Fight Diseases. EsoBiotec is a biotechnology company developing innovative therapeutics to fight cancer. Our mission is to empower the human body to tackle cancer by bringing in vivo engineering of cells to patients. We aim to develop cost-effective and off-the-shelf therapeutics and providing state-of-the-art cell therapies to maximise accessibility. Our disruptive approach holds the potential to transform the current standard of cell and gene therapies for cancer treatment. Gene therapy, Biotechnology, Oncology, Cell therapy, Cancer, in vivo engineering, virology, and Immunology Type: | 1 | 1 | 0 | 15 |
 | Hemispherian AS Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Our mission is to develop a new drug to treat Glioblastoma Multiforme. We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients. cancer treatments, GBM treatments, and therapeutics Type: | 2 | 0 | 1 | 10 |
 | IRLAB Therapeutics AB A clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's. IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam. IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its … Type: | 0 | 0 | 0 | 37 |
 | Hoba Therapeutics Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. Both indications have a clear unmet medical need for safe and efficacious treatments for millions of patients worldwide. Hoba Therapeutics is developing HB-086 for the treatment of chronic neuropathic pain. HB-086 is a non-opioid compound with a unique mechanism of action targeting the peripheral nervous system to reverse neuropathic pain and the underlying cause of the disease. The second drug candidate HB-097 is a pharmacological treatment for sensorineural hearing loss. Preclinical data of HB-097 … Type: | 0 | 0 | 0 | 15 |
 | MitoRx Therapeutics Our mission is to arrest the progression of degenerative diseases driven by mitochondrial dysfunction MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease. mitochondrial disease, rare disease, Duchenne, neuromuscular disease, DMD, biotech, preclinical, drug discovery, mitochondria, new class, MitoRx, MTRX-1, hyperhomocysteinemia, Huntington's, mitochondrial myopathy, muscular dystrophy, neurodegenerative disease, dementia, Huntington's disease, CBS-deficiency, muscular dystrophy, first-in-class, and first-in-target Type: | 1 | 0 | 1 | 14 |
 | ALKemist Bio Next generation cell therapies for ALK-positive cancer patients At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer patients. By harnessing the power of the immune system and engineering T cells to precisely recognize and combat these cancerous cells, we aim to pave the way for more effective treatments aiming at improving the standard of care. biotech, immunooncology, oncology, alkpositive, celltherapy, TCR, and ALK Type: | 0 | 0 | 0 | 3 |
 |  VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | Livinguard Technologies AG Enhancing the functionality & performance of materials across various applications through the power of surface charge. Livinguard Technologies is a Swiss material science company focused on enhancing the functionality & performance of materials across various applications through the power of surface charge. Our mission is to safeguard the wellbeing of people and the environment with our high performance, sustainable technology platform. Understanding that we have one planet with limited resources has shaped our approach to innovation. We help our partners change consumption patterns and processing parameters to limit the generation of waste and use of resources while maintaining highest standards … Type: | 3 | 0 | 2 | 14 |
 | Valence Labs Industrializing scientific discovery to radically improve lives. Powered by Recursion. Valence Labs, powered by Recursion, is industrializing scientific discovery to radically improve lives. Our vision is that highly autonomous systems capable of Nobel-worthy insights will usher in a new wave of scientific discovery. Following the acquisition of Valence Discovery by Recursion (NASDAQ: RXRX) in May 2023, Valence Labs continues as a semi-autonomous AI research engine within Recursion aiming to advance the frontier of deep learning in drug discovery. Valence Labs operates with the unique combination of the intellectual freedom of academia but the resources and stability of industry. Valence Labs … Type: | 12 | 1 | 9 | 51 |
 | BioMiMetiC [Automatic translation follows] Bio-waste recovery solution by entomo-conversion BioMiMetiC is the only company that designs integrated solutions for the recovery of bio-waste via the mass production of insects. Entomo-production, Bio-waste recycling, Biotechnology, Plant nutrition, Animal nutrition, Social and Solidarity Economy, CSR, Environment, Circular Economy, Agriculture, and Agri-food Type: | 7 | 8 | 0 | 6 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models Type: | 8 | 4 | 6 | 27 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 11 | 6 | 6 | 33 |
 | FIRALIS S.A. Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM). 1) BIOMARKER PRODUCTS Firalis develops BM-based diagnostic, prognostic and theranostic tools: ● RUO Kits (Research-Use-Only), based on validated innovative biomarkers ● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers 2) BIOMARKER R&D ● Development of proprietary BMs - Cardiovascular, Inflammatory, Autoimmune and Neurology ● Drug Safety & Drug Efficacy ● Patient Stratification ● Personalized Medicine 3) BIOMARKER-RELATED CRO SERVICES BM Discovery for … Type: | 19 | 4 | 5 | 32 |
 | Beta Innov [Automatic translation follows] Development in Immunology and Cancerology of innovative drugs with curative potential. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by families of patients. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of antibody therapies. Type: | 0 | 0 | 0 | 14 |
 |  BIOptimize BIOptimize is a company that delivers data mining tools and predictive models, using a specific methodology, focused on exhaustivity, simplicity and interactivity. BIOptimize is winner of the NETVA 2013 competition and the French Senate competition "Tremplin d'Entreprises" 2013 as being the best and more innovative and promising french company in the field of biotechnology Specialized in the detection of hidden informations in the scientific data, BIOptimize technology misses not any important information in your scientific data, from in silico Drug Discovery to Clinical Trials Opimization. BIOptimize developped an online sofrware BIOpticloud that can instantly analyze and expalin all your data, … Type: | 5 | 2 | 3 | 1 |
 | Sinnovial SAS [Automatic translation follows] Sinnotest® supports rheumatologists in optimizing the prescription of biotherapies in rheumatology SINNOVIAL is a biotechnology company that develops personalized medicine devices to improve the management of Chronic Inflammatory Rheumatism (CIR) in Rheumatology (rheumatoid arthritis, ankylosing spondylitis, in particular). Our mission: to improve the quality of life of patients by maximizing the chances of success of their treatment with biotherapy. Our goal: to provide the doctor with a device to help with therapeutic orientation that allows him, in real time, to optimize the selection of biotherapy. "The right treatment, for the right patient, at the right time!" Biotechnology, … Type: | 4 | 1 | 3 | 4 |
 | PHARNEXT New therapies for neurodegenerative diseases Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s … Type: | 5 | 4 | 2 | 21 |
 | CERTIS Therapeutics Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation Type: | 3 | 3 | 0 | 14 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 18 | 7 | 9 | 19 |
 | Corlieve Therapeutics At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. Type: | 2 | 2 | 0 | 2 |
 | Ennolys by Lesaffre Your partner in fermentation solutions Ennolys uses the advances in biotechnology to assist aromaticians, food manufacturers, perfumeries, and nutraceuticals. This business unit from Lesaffre combines two activities in relation to fermentation expertise. Ennolys develops a wide range of natural aromatic molecules, including the vanillin. With excellent flexibility, its industrial tools guarantee fermentation services of a wide range of natural ingredients such as probiotics and ensure their post-processing. 100 employees around the world are committed to the natural approach, client satisfaction and innovation. Our mission is to reveal the infinite potential of microorganisms. fermentation, aroma molecules, biotechnology, and contract manufacturing Type: | 1 | 0 | 1 | 62 |
 | MAAsiRNA MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to … Type: | 1 | 1 | 0 | 5 |
 | Blue Bees Therapeutics Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug Type: | 7 | 4 | 0 | 8 |
 | Diotheris Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance. antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA Type: | 1 | 1 | 0 | 1 |
 | Deeptope Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation Type: | 2 | 2 | 0 | 7 |
 | Kimialys Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, … Type: | 15 | 4 | 8 | 17 |
 | AberActives SAS [Automatic translation follows] Biorefining marine algae for nutraceuticals and cosmetics AberActives is a marine biotechnology company Our laboratory is located on the Laber site in the premises of the Roscoff marine station, a global center of excellence in fundamental research on algae. The start-up proposes the use of bacterial enzymes to transform algal sugars with a view to manufacturing ingredients in cosmetics and/or health nutrition. Type: | 10 | 3 | 0 | 8 |
 | Sirius NeoSight [Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company whose ambition is to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic efficacy implemented. Sirius NeoSight uses a patented breakthrough technology from a consortium of academic laboratories that are experts in the field. Type: | 17 | 6 | 6 | 4 |
 | Oncofactory 🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic … Type: | 5 | 1 | 4 | 8 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … Type: | 3 | 2 | 1 | 41 |
 | DimiCare Biotech goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from Université Côte d'Azur, INSERM and CNRS focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, … Type: | 12 | 2 | 4 | N/A |
 | NERVOSAVE THERAPEUTICS Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome. Type: | 3 | 1 | 0 | 4 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish Type: | 4 | 3 | 1 | 5 |
 | Diamidex Make Visible the Invisible Faster to Make your World Safer Founded in 2014, DIAMIDEX (Diagnostic Microbiology Express) is an innovative company specialized in the detection and quantification of microorganisms of interest. Its mission: making the invisible visible faster, to make your world safer. Its patented innovative technological approach brings about a major breakthrough to meet the speed and technicality challenges arising from microbiological culture. Based on a powerful technological platform, recognized by the scientific and industrial communities, DIAMIDEX offers and develops turnkey test solutions, which can be used in both laboratories and in the field to obtain a quantitative count … Type: | 14 | 7 | 9 | 28 |
 | Pili carbon conscious color company Pili, carbon conscious color company Pili is the leader in bio-based colorants and pigments. Its unique fermentation and sustainable chemistry processes, enable the production of high-performance, and low-carbon colors. Its technology aims at decarbonizing the color industry by drastically reducing the use of chemicals and fossil resources, particularly oil. Its products are designed for the textile, inks, paints & coatings and plastics sectors. Founded in 2015, Pili operates from 3 different sites: Toulouse White Biotechnology (TWB), Paris and the Roches-Roussillon industrial platform in Isère. With around 40 employees to date, the company has invested over €35 … Type: | 25 | 13 | 13 | 62 |
 | SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … Type: | 17 | 5 | 14 | 9 |
 | Eurofins CALIXAR Native and functional membrane therapeutic targets for improving Drug and Vaccine Discovery To contact us : contact@calixar.com CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens. We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High … Type: | 13 | 7 | 7 | 17 |
 | CYTOO CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health Type: | 2 | 1 | 0 | 34 |
 | SPIRIS Spirulina is a microalgae taken for its high content in proteins, iron, vitamins and anti-oxydants. It is considered as an efficient mean to fight malnutrition, reinforces the immune system, or prevents cardiovascular diseases. The technology developed by Spiris considerably enhances spirulina productivity and reduces significantly its production costs. Spiris has the ambition to produce and commercialise a high quality spirulina, while reducing water consumption and increasing CO2 absorption produced by biogas combustion. Micro-Algae Production, Micro-Algae R&D, and Process Innovation Type: | 0 | 0 | 0 | 1 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … Type: | 0 | 0 | 0 | 6 |
 | ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: | 2 | 1 | 2 | 8 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … Type: | 11 | 3 | 9 | 7 |
 | IMODI Cancer Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer Type: | 1 | 0 | 0 | N/A |
 | KCAS Bio - Lyon Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. … Type: | 2 | 1 | 2 | 30 |
 | Vidium Solutions Data analysis and in silico modelization solutions for genetic research and personalized medicine Expert in systems biology, VIDIUM brings data analysis and in silico modelization solutions for genetic research. We unlock the power of single-cell analysis to characterize and master the complexity of cell fate dynamics: "As Google did for urban networks, we built our navigation map in cellular genetic networks!" Guided by knowledge-driven approaches, we create highly representative digital twins from single-cell data, to make accurate predictions. These in silico avatars of genetic networks allows us to "find our way" through the billions of possible interactions between our 20,000 … Type: | 5 | 0 | 4 | 7 |
 | AUROBAC THERAPEUTICS Developing precision medicines to combat bacterial infections, AMR, and their consequences in acute care settings. AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines to combat bacterial infections, Antimicrobial Resistance (AMR), and their consequences in acute care settings. AUROBAC’s R&D strategy addresses these unmet medical needs with patient- and pathogen-targeted programs designed to tackle both the causes and consequences of potentially life-threatening bacterial infections and AMR, including hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) and sepsis. Central to … Type: | 4 | 1 | 3 | 24 |
 | MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of extracting metals specifically, quickly and in a controlled manner. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: | 12 | 2 | 3 | 13 |
 | ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … Type: | 1 | 1 | 0 | 10 |
 | Cellenion Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation … Type: | 3 | 1 | 2 | 25 |
 | HEPHAISTOS-Pharma [Automatic translation follows] Developing the weapons that we need to defeat cancer. HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by increasing the effectiveness of monoclonal antibodies and allowing the treatment of incurable tumors. Oncology, immunotherapy, and cancer | 23 | 11 | 6 | 11 |
 | Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: | 11 | 4 | 9 | 8 |
 | ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon Type: | 6 | 1 | 5 | 12 |
 | NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: | 32 | 10 | 27 | 38 |
 | Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: | 18 | 5 | 13 | 52 |
 | KUSTE BIOPHARMA KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science KUSTE is a Clinical Stage Biopharma Company founded by seasoned entrepreneurs in Life Science with the aim of tackling major chronic inflammatory diseases | 1 | 1 | 0 | 1 |
 | MedActiv MedActiv is a global leader in the development of transport and storage solutions for sensitive medication. Our products are designed to give users the freedom to travel knowing that their medication is kept at exactly the right temperature. As the chosen partner of major pharmaceutical companies worldwide, MedActiv is constantly pushing back the boundaries of this industry. The MedActiv solutions are specially designed to bring added value to the medications they are made for. Strategically located in France, UK, USA, Australia and Taiwan, we have the reputation of always anticipating the needs of our customers with an approach that is … Type: | 7 | 3 | 3 | 6 |
 | BioPharmAnalyses [Automatic translation follows] BioPharmAnalyses is an information site that allows you to actively monitor and follow the strategic developments of companies in the biopharmaceutical sector. With BioPharmAnalyses: • You get a summary view of recent news in the sector • You are aware of the latest key agreements and mergers and acquisitions • You follow the clinical and regulatory progress of products in development • You access the latest subsidies, fundraising and IPOs Its five databases contain more than 13,000 interactive files on agreements, clinical trials, fundraising, mergers/acquisitions and the regulatory life of biopharmaceutical products in Europe and the United … | 16 | 0 | 16 | 2 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: | 3 | 2 | 1 | 16 |
 | Depixus Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics Type: | 2 | 2 | 0 | 63 |
 | Nahibu MICROBIOME PROFILING Nahibu is a leading global microbiome company offering NGS analysis, advanced analytics, and end-to-end research support. Our platform provides the most extensive metagenome and metadata catalog for data mining and microbiome association discovery. Type: | 15 | 4 | 1 | 9 |
 | NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. Type: | 1 | 1 | 0 | 9 |
 | CELLOMET CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the … Type: | 2 | 0 | 1 | 4 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech Type: | 13 | 3 | 10 | 13 |
 | Carroucell Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade! Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications. Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents. In 2022, … Type: | 2 | 2 | 0 | 5 |
 | Bon Vivant Animal-free dairy proteins, for a sustainable future. We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and … Type: | 53 | 13 | 40 | 113 |
 | Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … Type: | 4 | 3 | 0 | 1 |
 | LifeScientis [Automatic translation follows] Development of Innovative Solutions for the Encapsulation of Active Ingredients & Toxicological Risk Assessment Strategies Our origins: ✔ Toxicologist and endocrine disruption expert Franck Chuzel decided to launch a human-sized company aimed at "doing his part" in the collective effort to improve the well-being and health of people while respecting our planet. After 20 years spent in large industrial groups in the life sciences industry as head of safety assessment units, and having matured his business plan during his Executive MBA at EMLyon, he founded the innovative company LifeScientis in 2015 to offer two complementary services. On … Type: | 4 | 1 | 3 | 6 |
 | Beacon Biosignals Our mission is to improve human health by enabling rapid, targeted interventions through advanced brain analytics. Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain. Type: | 23 | 10 | 8 | 78 |
 | SeqOne From Genome to Personalized Medicine Founded in 2017, SeqOne Genomics headquartered in Montpellier, France, is a fast-growing deep-tech company focused on turning genomic data into medically actionable insights in oncology, rare and inherited diseases. SeqOne clinical genomic analysis platform, powered by explainable AI, provides genomic labs and healthcare professionals with best-in-class accuracy, usability, and automation seamlessly across lab technologies. By streamlining complex multi-omics analysis workflows, we pave the way for a new era of personalized healthcare at scale, where genetic testing becomes as routine as traditional blood work, radically enhancing health outcomes for all. The company has won numerous awards, … Type: | 14 | 6 | 8 | 87 |
 | COCONT [Automatic translation follows] Fast and unique turnkey plant production Company specializing in the development and production of fermented or non-fermented plant alternatives with high nutritional value. | 5 | 3 | 0 | 4 |
 | PEAK LIFECYCLES HR - Europe & the US Beyond the people you want, get the people you need PEAK LIFECYCLES HR is an international Executive Search and Talent Management company dedicated to Global "Care environment" markets and their stakeholders. Placing the analysis of the business life cycle, and that of products, skills, and projects at the heart of its activity, Peak Lifecycles' unique, innovative expertise is founded on its anticipation of market requirements. OUR OFFERS: Executive Search, Talent Management, Organizational audit, Executive Coaching We also developed an offer dedicated to Startups and their lifecycles. Executive Search, Talent Management, Life Sciences, Market Access, Medical, Business Operation, Digital , Food, … Type: | 25 | 0 | 23 | 12 |
 | CST - Crime Science Technology Crime Science Technology (CST) develops innovative solutions for identifying persons and securing of documents and products. These solutions are based on innovations developed with the CNRS (French National Center for Scientific Research) and the Ecole Normale Supérieure de Cachan. In the forensic field, our expertise also relies on numerous synergies with public institutions such as the French Forensic Medicine Institute and the INPS (National Institute for Forensic Science). Moreover, it is supported by ongoing exchanges with Technical and Scientific Polices abroad. CST has developed and markets since 2013, the LUMICYANO : the first one step fluorescent cyanoacrylate used for development … Type: | 38 | 3 | 38 | 13 |
 | SMARTOX Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library Type: | 0 | 0 | 0 | 7 |
 | TiHive Terahertz-AI Vision. Terahertz-AI Vision company, disrupting industrial process and quality monitoring for a more sustainable and efficient industry. We are an imaging and sensing company providing Terahertz and Artificial Intelligence solutions for industrial quality and process control, sensing, and communications. We are proud to serve customers around the world, with passion and determination to help industries produce the best quality products while getting the most out of the raw materials. We have developed state of the art in-line imaging and sensing systems based on mmwaves and terahertz see-through nanotechnology allied to deep learning that analyse within materials and objects at … Type: | 19 | 3 | 18 | 12 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 5 | 3 | 2 | 8 |
 | shazino Shazino is a young start-up company developing innovative computer tools to improve laboratory data management: • Hivebench: Laboratory notebook & inventory in the cloud (https://www.hivebench.com), • Papership: Manage annotate and share your Papers on-the-go, on your iPhone/iPad (https://www.papershipapp.com), • PLASMID.IO: Get, Manage & Share your Plasmids. It's a child's play! (https://www.plasmid.io), • Fast Counter: Conduct Biology Experiments on your iPhone (http://itunes.apple.com/app/fast-counter/id529461202), • Lab Timer: The timer on-the-go, on your iPhone/iPad (http://itunes.apple.com/app/laboratory-timer/id537195348). Fore more information: take a tour of our solutions at http://www.shazino.com. Computer Science, Biotechnology, Web Development, and Apple Platforms Type: | 1 | 1 | 0 | 2 |
 | Instituto de Ciencia de Materiales de Madrid (ICMM - CSIC) Our mission is to generate new fundamental and applied knowledge on materials and processes with added value The Instituto de Ciencia de Materiales de Madrid (ICMM) is an institute of the Consejo Superior de Investigaciones Cientificas (CSIC) (Spanish National Research Council) founded in December 1986, that belongs to the Area of Science and Technology of Materials, one of the eight Areas in which the CSIC divides its research activities. Our mission is to create new fundamental and applied knowledge in materials of high technological impact, their processing, and their transfer to the productive sectors at local, national and European scales … Type: | 8 | 2 | 3 | 180 |
 | Pharmaron Premier life science service provider Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * … Type: | 4 | 1 | 1 | 1,856 |
 | Stratégique Santé [Automatic translation follows] Health economics consulting and training Specialists in health market access strategies and health policies, we support you in all your issues related to the health or medico-social sector. Our consultants are also specialized in hospital management and public health. market access, HEOR, Health regularoty, medico-economic study, and PMSI Type: | 0 | 0 | 0 | 1 |
 | Seratec [Automatic translation follows] Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. With internationally recognized French know-how, we design, develop, produce and register dossiers for pharmacologically active molecules with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to the quality standards known as Good Manufacturing Practices (GMP 2 or … Type: | 9 | 0 | 9 | 27 |
 | ASTRUM CRO France (POPSI CUBE) Agile Clinical & Digital Pan European Contract Research Organization (CRO) We are a Pan European Clinical Contract Research Organization (CRO), We offer to our Pharmaceutical, Biotech and Medtech partners a complete outsourcing of their clinical trials from phase I to phase IV by integrating the entirety of the value creation chain of medical product development activity. The origin of Popsi Cube is a convergence between a solid clinical process and effective IT tools. A CRO with integrated tools to address the entire clinical research functional scope. A successful project management requires top quality human resources but also a set of … Type: | 0 | 0 | 0 | 17 |
 | Holodiag API Characterization, Polymorphism, Screening & Crystallization Process Holodiag is a Contract Research Organization founded in 2006 dedicated to solid state and crystallization processes of small molecules, mainly APIs. We provide our customers with: ¤ Analytical characterizations: Holodiag is equipped with XRPD, DSC, TGA, DVS, FTIR, Laser PSD, IDR and more. All analyses are available on toxic samples down to 50 ng/m3. ¤ Solid state investigations: Screenings of polymorphs, salts, co-crystals. Properties investigations on stability, solubility, dissolution. ¤ Crystallization processes: Development from scratch, optimization of existing process, trouble shooting. Investigations on product recovery, isomer separation, filtration, drying, particle engineering, control of … | 0 | 0 | 0 | 12 |
 | TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: | 0 | 0 | 0 | 1 |
 | Skye Bioscience Inc. Unlocking new therapeutic pathways for metabolic health Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye plans to start a Phase 2 clinical trial in obesity in Q3 2024 for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, comparing monotherapy and combination arms of nimacimab and a GLP-1R agonist (Wegovy®). Type: | 3 | 2 | 1 | 17 |
 | Generis Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our … Type: | 91 | 2 | 91 | 115 |
 | Immune Biosolutions inc. Actor of change Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development. Anticorps, Custom antibody development, Antibody, Développement sur mesure de génération d'anticorps, IgY, Chicken, Poulet, ELISA, Therapeutic Antibodies, Recombinant Antibodies, Humanized Antibodies, GPCRs, and Oncology Type: | 6 | 1 | 1 | 25 |
 | Sedna Technologies Unleashing the power of data and technology within the seafood sector Sedna Technologies is a fisheries technology firm based out of Nova Scotia, Canada. The focus of Sedna is to increase the traceability of seafood products by creating innovative and simple to use software solutions for exporters, processors, distributors and harvesters involved in international and domestic trade. Our systems are built from the ground up, ensuring they are easy to implement and maintain. We design our systems to your specifications; our technology can allow for your clients to understand the origin and journey of your products. Allowing for greater marketability … Type: | 0 | 0 | 0 | 5 |
 | DNAstack DNAstack creates software to accelerate breakthroughs in genetic research and precision medicine. DNAstack creates cutting edge software technologies that help scientists more easily discover, access, and analyze the world’s exponentially growing volumes of genomic and clinical data. genomics, bioinformatics, cloud, and big data Type: | 8 | 0 | 6 | 32 |
 | Incuvers Visualize, Connect, and Explore Every Moment of Cellular Research. Incuvers is a hardware + software company developing live cell imaging incubators for cellular researchers. Our flagship product, IRIS (Incuvers Real-time Imaging System) is the most advanced and affordable system for cell culture incubation. Combining hypoxic incubation, live cell imaging, and cloud computing, IRIS lets researchers capture time lapse videos of their entire experiments and monitor them live from anywhere, without ever taking them out of the incubator. The Incuvers mission is to “Visualize, connect, and explore every moment of cellular research”. Type: | 0 | 0 | 0 | 1 |
 | Astral Solutions Group Corporate Performance Management Consulting and Support Services Provider | OneStream Software | Oracle EPM | Anaplan At Astral Solutions Group, we provide Consolidation, Planning, Budgeting and Forecasting, Financial Reporting, Sales Profitability, Costing implementation services to the Office of Finance. Astral Solutions Group is a trusted OneStream Software Implementation and Oracle Service Partner. Industries We Serve: Manufacturing, Construction, REIT, Pharmaceuticals, Banks, Mining, Higher Education, We are experienced in addressing the requirements of an organization from project inception through the successful delivery and adoption of the completed solution. Software Expertise: #OneStreamSoftware #OracleEPM #Hyperion Oracle EPM On-Cloud Enterprise Planning and Budgeting … Type: | 2 | 0 | 1 | 19 |
 | Reddot Biotech Inc. We focus on the production and sales of high quality ELISA Kits, antibodies, and molecular biology products. We focus on providing customers in the global marketplace with timely customer service, reliable supply, and products with superior quality and performance. We thrive on competition, innovation and fast resource allocation for customer needs. Reddot Biotech Inc. currently focuses on the sales of ELISA kits for pharmaceutical, laboratory, medical and scientific research use. We currently provide more than 6000 different kinds of ELISA kits. We are committed to R&D to bring customers top quality products providing accurate, reliable and fast results. With extensive … Type: | 0 | 0 | 0 | 5 |
 | Entourage Health Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s … Type: | 1 | 0 | 1 | 123 |
 | Aspect Biosystems Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. bioprinting, tissue … Type: | 10 | 0 | 8 | 110 |
 | Extem Extem Bioscience has been developing advanced technologies for the use of regenerative medicines and is expanding our offerings. We have identified 3 key areas that will undergo drastic shifts over the next 10 years and are in need of a multidisciplinary evidence based approach. By collaborating and co-developing with leading institutions within North America we see a brighter, healthier and trans formative future. | 0 | 0 | 0 | 1 |
 | NURO CORP. Manufacturer of the NUOS platform allowing patients to communicate and compute by brain, instantly and without surgery. The Manufacturer of NUOS. NUOS allows any human being to communicate and compute by Brain. Instantly and without any surgery. Visit www.nuro.ca for more information. - 2017 Canada's FedDev Award Recipient. - 2018 Grand Prize Winner of 2 MIT Competitions: The MIT Future of Healthcare Hacking and the MIT Barracuda Bowl (across all Healthcare disciplines). - 2018 Canada's NRC-IRAP Award Recipient. - 2019 Province of Ontario's MaRS Discovery District Award Recipient. - 2019 Waterloo MedTech Top Start-Up Award Recipient. - 2019 Ontario Centres … | 9 | 1 | 6 | 3 |
Startup